Aspirin trial extended

A landmark study tracking the effects of low-dose aspirin on the health of older people has been extended for five years Researchers at Monash University and the US-based Berman Center for Outcomes and Clinical Research, part of the Hennepin Healthcare Research Institute, are expanding on the landmark aspirin trial, ASPREE, with a five-year follow up

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Medicines costs a factor in healthcare inequality: McBride
Next 7 things to know about meningococcal vaccines